ArticleJournal of assisted reproduction and genetics2026
Mitochondrial DNA to genomic DNA ratio in embryo spent culture medium as a predictive marker for in vitro fertilization outcomes: a pilot study.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
purposeThis study aimed to determine whether the mitochondrial DNA to genomic DNA (mtDNA/gDNA) ratio in spent culture medium (SCM) can reliably predict embryo quality and clinical pregnancy outcomes in in vitro fertilization (IVF). Current embryo selection methods rely primarily on morphological assessment, which has limitations in predicting implantation success and cannot distinguish aneuploid embryos.
methodsA prospective clinical trial was conducted from July 2022 to July 2023 involving 174 women with unexplained infertility undergoing IVF-ICSI at CHA University, Korea. Day 5 blastocyst culture media were analyzed for mtDNA/gDNA ratio using quantitative real-time PCR. Embryos were evaluated using a blastocyst scoring system (BS) categorizing them as good (BS 3-5), fair (BS 6-9), or poor (BS 10-14). Statistical analyses included correlation analysis and ROC curve analysis to assess the predictive value for clinical pregnancy rates.
resultsHigher mtDNA/gDNA ratios correlated significantly with lower embryo quality grades (good: 1.12, fair: 1.15, poor: 2.14; p < 0.001). ROC analysis confirmed the mtDNA/gDNA ratio as a reliable predictor of clinical pregnancy rates with AUC > 0.8 (p < 0.001) across all age groups. No significant differences in clinical pregnancy rates were observed across different age groups (p = 0.392).
conclusionThe mtDNA/gDNA ratio in SCM shows promising potential as a non-invasive indicator of embryo quality and clinical pregnancy outcomes. However, given the exploratory nature of this study and current methodological limitations, further validation with larger, independent cohorts and standardized analytical protocols is required before clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.